“It’s an exciting time at RVL Pharmaceuticals. In 2021, we executed our strategy to focus on ocular medicine and periocular rejuvenation. We divested our legacy business, fully repaid our term loans, ...

“RVL is off to a great start on the year. Our one-of-a-kind product continues to exhibit year-over-year growth as we leverage our cost base for improved efficiency. Our multi-channel strategy is ...

RVL Pharmaceuticals plc's (NASDAQ:RVLP) several operating subsidiaries are filing for bankruptcy in a prepackaged deal with lender Athyrium Capital and other key stakeholders. The reorganization will ...

It is a pleasure to report that the RVL Pharmaceuticals plc (NASDAQ:RVLP) is up 107% in the last quarter. But that doesn't help the fact that the three year return is less impressive. After all, the ...

RVL Pharmaceuticals (NASDAQ:RVLP) has priced an offering of its ordinary shares to raise $5 million. The company said it will offer 11,870,846 shares at $0.4212 apiece. The company also agreed to ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

SALT LAKE CITY--(BUSINESS WIRE)--MonaVie (www.monavie.com), maker of premier acai berry juice–based nutrition and energy drink products, officially unveiled MonaVie RVL Premier Weight Solution ...